Source: Neuropathology. Unidades: SVOI, FMRP
Subjects: MEDULOBLASTOMA, CRIANÇAS
ABNT
LEAL, Letícia Ferro et al. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma. Neuropathology, v. 38, n. 5, p. 475-483, 2018Tradução . . Disponível em: https://doi.org/10.1111/neup.12508. Acesso em: 02 nov. 2024.APA
Leal, L. F., Evangelista, A. F., Paula, F. E. de, Almeida, G. C. de, Carloni, A. C., Saggioro, F. P., et al. (2018). Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma. Neuropathology, 38( 5), 475-483. doi:10.1111/neup.12508NLM
Leal LF, Evangelista AF, Paula FE de, Almeida GC de, Carloni AC, Saggioro FP, Stavale JN, Malheiros SMF, Mançano B, Oliveira MA de, Luu B, Neder L, Taylor MD, Reis RM. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma [Internet]. Neuropathology. 2018 ; 38( 5): 475-483.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1111/neup.12508Vancouver
Leal LF, Evangelista AF, Paula FE de, Almeida GC de, Carloni AC, Saggioro FP, Stavale JN, Malheiros SMF, Mançano B, Oliveira MA de, Luu B, Neder L, Taylor MD, Reis RM. Reproducibility of the NanoString 22-gene molecular subgroup assay for improved prognostic prediction of medulloblastoma [Internet]. Neuropathology. 2018 ; 38( 5): 475-483.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1111/neup.12508